http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201326817-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4dfadc85880dea751f1bf8287b78697c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate | 2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d40a4b149adfd63b1c732aeb959c006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d99040e759f2f0fc8941f02c1878fc46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96047c5946e37947faea96d23ae3a496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8de471674edf45e480d945c12a2dff44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67ddf23e8d5ee796e678bb3aa1e8b2b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3729d19a04c2c83cfd9403ca3f6bc2f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68efbc35831d9e4ed24487d6532ae3b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3a10d50e4e433365524ac2ec1d98e19 |
| publicationDate | 2013-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201326817-A |
| titleOfInvention | Use of Streptococcus pneumoniae neuraminidase as a method for diagnosing and preventing pneumococcal infections |
| abstract | The present invention provides a method for diagnosing and preventing Streptococcus pneumoniae infection by using Streptococcus pneumoniae neuraminidase, mainly for the development of a vaccine for preventing infection of Streptococcus pneumoniae and for diagnosing a chest cavity from urine, blood and empyema. Whether the sample such as effusion is infected with Streptococcus pneumoniae. According to the present invention, in the case of hemolytic uremic syndrome (HUS) caused by Streptococcus pneumoniae, most of the S. pneumoniae carry three neuraminidase genes (nanA, nanB and nanC genes), although anti-NanC serum inhibition or Neutralizing neuraminidase activity is not as good as anti-NanA and anti-NanB serum, but combining the three neuraminises together is the best vaccine reagent, which can be used as an ideal vaccine test to provide the best protection. To combat the infection of Streptococcus pneumoniae, to achieve a good effect. |
| priorityDate | 2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 202.